Types of Manuscripts
ARTICLE CATEGORIES
Types of Manuscripts
Scholarly contributions considered within the journal's scientific scope.
CRJPAS proposes the following manuscript categories for scholarly research in pharmaceutical and allied sciences. All submissions must demonstrate scientific relevance, methodological rigor and compliance with publication ethics requirements.
| Article Type | Suggested Word Limit | Abstract |
|---|---|---|
| Original Research Article | 3,000–6,000 | 200–300 words, structured |
| Narrative Review Article | 4,000–8,000 | 200–250 words |
| Systematic Review / Meta-analysis | 4,000–8,000 | 200–300 words, structured |
| Short Communication | 1,500–2,500 | 150–200 words |
| Case Report | 1,500–3,000 | 150–200 words |
| Editorial / Perspective | 800–1,500 | Not normally required |
Original Research Articles
Original Research Articles report novel experimental, clinical, analytical or translational studies that make a substantive contribution to pharmaceutical sciences. Manuscripts should follow the IMRAD structure and provide sufficient methodological detail to evaluate the validity of the findings.
Review Articles
Review Articles provide critical and evidence-based syntheses of existing scientific literature. Reviews should offer balanced interpretation, identify unresolved research questions and explain the significance of current evidence.
Systematic Reviews and Meta-Analyses
Systematic Reviews and Meta-Analyses must employ transparent, reproducible methods for identifying, selecting, appraising and synthesizing relevant research. PRISMA reporting standards should be followed.
Short Communications
Short Communications present concise reports of scientifically meaningful findings, methodological innovations or preliminary investigations supported by sufficient evidence.
Case Reports
Case Reports should describe unusual or educational clinical observations with clear relevance to pharmacotherapy, medication safety, pharmaceutical care or related biomedical fields. Appropriate patient consent and CARE reporting guidance are expected.
Editorials and Perspectives
Editorials and Perspectives discuss scientific developments, research priorities and issues relevant to pharmaceutical scholarship. These contributions are generally commissioned or considered at the discretion of the editorial leadership.
Note: Word limits exclude the abstract, references, tables and figure legends. The final article categories and limits require approval by the editorial board.